Published on
05-27-21 at 5:31 am
in Brussels (Belgium)
From June 1, the preventive treatment for migraine Aimovig from Novartis will be reimbursed in Belgium for adults suffering from at least eight days of migraine per month and having previously tried at least three prophylactic treatments (preventive, Editor’s note) without success. co-payments will amount to 12.10? for an ordinary insured patient and at 8.00? for a patient with BIM status (ex VIPO). Excluding reimbursement, the monthly cost of the drug will amount to 491.32 euros. (Belga)
© 2021 Belga. All rights of reproduction and representation reserved. All the information reproduced in this section (dispatches, photos, logos) are protected by intellectual property rights held by Belga. Consequently, none of this information may be reproduced, modified, redistributed, translated, commercially exploited or reused in any way whatsoever without the prior written consent of Belga.
–
